Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An ecosystem approach to the evaluation and impact analysis of heterogeneous preventive and/or early interventions projects for veterans and first responders in seven countries.

Comprehensive psychiatry·2025
Same author

Utilising a modified accelerated Delphi process to develop a national multidisciplinary consensus on peri-operative optimisation of patients with obesity undergoing non-bariatric surgery.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2024
Same author

Calculus Removed by Dilatation of the Urethra.

Medical examiner (Philadelphia, Pa.)·2023
Same author

Norwich COVID-19 testing initiative pilot: evaluating the feasibility of asymptomatic testing on a university campus.

Journal of public health (Oxford, England)·2020
Same author

The transcriptional landscape of polyploid wheat.

Science (New York, N.Y.)·2018
Same author

The environmental and host-associated bacterial microbiota of Arctic seawater-farmed Atlantic salmon with ulcerative disorders.

Journal of fish diseases·2017
Same journal

Combination of paclitaxel with eugenol effectively enhances anticancer characteristics of paclitaxel on the A549 lung cancer cell line.

Cytotechnology·2026
Same journal

RBM15 enhances ILDR1 n6-methyladenosine methylation to accelerate gastric adenocarcinoma progression via an IGF2BP3-dependent manner.

Cytotechnology·2026
Same journal

Apigenin attenuates hepatocyte senescence in metabolic dysfunction-associated steatotic liver disease by targeting the TGF-β signaling pathway.

Cytotechnology·2026
Same journal

Iodine-125 seed induces ferroptosis through inhibiting RNF216-mediated ubiquitination of p53 in cholangiocarcinoma cells.

Cytotechnology·2026
Same journal

Magnetic resonance imaging-based Alzheimer's disease detection using an EfficientNet-CMSACCN framework.

Cytotechnology·2026
Same journal

Brusatol Induces Ferroptosis in Condyloma Acuminatum Keratinocytes by Suppressing Nrf2 via Inhibition of the PI3K/AKT Pathway.

Cytotechnology·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

The extended-MDR phenotype.

R Davey1, M Davey

  • 1Clinical Oncology Department, Royal North Shore Hospital, Bill Walsh Cancer Research Laboratories, St. Leonards, 2065, Australia., rdavey@med.usyd.edu.au.

Cytotechnology
|November 13, 2008
PubMed
Summary
This summary is machine-generated.

Cellular models reveal extended multidrug resistance (MDR) mechanisms. Low-dose, intermittent chemotherapy can generate broad drug cross resistance, mimicking clinical cancer treatment failure.

More Related Videos

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Quantitative Approaches for Studying Cellular Structures and Organelle Morphology in Caenorhabditis elegans
08:47

Quantitative Approaches for Studying Cellular Structures and Organelle Morphology in Caenorhabditis elegans

Published on: July 5, 2019

Related Experiment Videos

Last Updated: Jun 28, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Quantitative Approaches for Studying Cellular Structures and Organelle Morphology in Caenorhabditis elegans
08:47

Quantitative Approaches for Studying Cellular Structures and Organelle Morphology in Caenorhabditis elegans

Published on: July 5, 2019

Area of Science:

  • Molecular biology
  • Cancer research
  • Pharmacology

Background:

  • Cellular models are crucial for understanding chemotherapy drug resistance mechanisms.
  • Existing models often use high drug doses, generating multidrug resistance (MDR) but not broad cross-resistance seen in refractory cancers.
  • A subset of models exhibits resistance to diverse drug classes, including natural products, alkylating agents, and antimetabolites.

Purpose of the Study:

  • To review factors promoting extended multidrug resistance (MDR).
  • To characterize cell sublines exhibiting extended MDR.
  • To explore potential resistance mechanisms involved in extended MDR.

Main Methods:

  • Review of existing literature on cellular models of drug resistance.
  • Analysis of studies reporting cell sublines with broad drug cross-resistance.
  • Identification of common features in the generation and characteristics of extended-MDR sublines.

Main Results:

  • Extended multidrug resistance (MDR) can be generated by intermittent exposure to low, clinically relevant drug doses.
  • These models display resistance beyond typical MDR, including to alkylating agents and antimetabolites.
  • The development of extended MDR is influenced by specific treatment protocols and cellular responses.

Conclusions:

  • Cellular models generated with low-dose, intermittent chemotherapy better recapitulate clinical multidrug resistance (MDR) phenotypes.
  • Understanding extended MDR is vital for developing strategies to overcome treatment failure in cancer.
  • Further research into the molecular mechanisms underlying extended MDR is warranted.